'Generic drug' presentation slideshows

Medicare Part D for Professionals Overview and Updates for 2014

Medicare Part D for Professionals Overview and Updates for 2014 . Sarah Pitsoulakis sarah.pitsoulakis@drwi.org Kate Schilling kate.schilling@gwaar.org Pamela Franke pjf@legalaction.org Ginger Rogers ginger.rogers@drwi.org September 25 & 26, 2013 . Agenda Part 1. What is Part D

1.72k views • 162 slides

Global Pharmaceutical Industry

1.74k views • 125 slides

Overview of Mental Health Medications for Children and Adolescents

968 views • 80 slides

Overview of Mental Health Medications for Children and Adolescents

911 views • 80 slides

Drugs

1.22k views • 67 slides

What You Want to Know About Generic Drugs

1.28k views • 53 slides

Development & The US FDA Approval of Generic Drugs

Development & The US FDA Approval of Generic Drugs. May 18, 2011 | Beijing, China SHAO Jun , Ph.D. Agenda. About Generic Drugs Business Strategy for Generic Drugs Generic Drug Product Development Generic Drug Approval Process Question-Based Review Summary. What are Generic Drugs.

878 views • 35 slides

Practice Basics

Practice Basics. Chapter 13: Processing Medication Orders and Prescriptions . Inpatient Pharmacies. Receiving Medication Orders hand-delivered mechanical method fax transmission or pneumatic tube Computer physician order entry, or CPOE orders verified by pharmacisst Telephone orders

570 views • 33 slides

Global Classrooms

320 views • 24 slides

Medical and Prescription Drug Plan Choices

350 views • 23 slides

Benefits of a treaty on R&D Session on alternative frameworks to finance R&D

James Love The Drugs for Neglected Diseases (DND) Working Group Rio de Janerio, Brazil 3 December 2002. Benefits of a treaty on R&D Session on alternative frameworks to finance R&D. How do we fund R&D?. Public and Donor Funds Direct Indirect Research Mandates Intellectual Property Rights

556 views • 22 slides

Regulation of Generic Drugs

Regulation of Generic Drugs. Office of Generic Drugs Craig Kiester Regulatory Support Branch. Mission Legislative History and Waxman-Hatch What is a Generic Drug? Patents/Exclusivity Orange Book. Outline. OGD Mission.

583 views • 21 slides

293 views • 18 slides

Marcel H.N. Hoefnagel 2 November 2007

Marcel H.N. Hoefnagel 2 November 2007. BIOSIMILARS are not Generics But similar. Content. Generics and Biosimilars Review for Marketing Authorisation Efficacy and Safety Pharmacovigilance Conclusion

364 views • 13 slides

WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO rou

WHO-Health Action International project on drug price comparisons A technical project of the WHO-Public interest NGO round table on access to medicines. Background. Evidence from small-scale studies that retail price for some drugs is higher in low income countries than in high income settings

216 views • 12 slides

GADA Quarterly Meeting October 8, 2009

GADA Quarterly Meeting October 8, 2009 . Dr. Ken Harshman, Director Division of Generic Animal Drugs. Comparative Dissolution for Solid Oral Dosage Forms. Principle: evidence must be provided to establish in vivo bioequivalence for all strengths of the generic drug Types of evidence

239 views • 12 slides

Drug Forms. Development of Drug.

382 views • 9 slides

Claims Incurred by Plan Members

Claims Incurred by Plan Members. Plan Design.

98 views • 5 slides

Results Data was collected on a total of 1800 prescriptions

Limitations Only 6 payers used. Results limited to one independent pharmacy. Small sample for each payer per year. Acquisition cost estimates did not include wholesaler rebates. The overall average GM was not weighted by the percent of prescriptions dispensed under each payer. Results

80 views • 1 slides

Group Name Plan Year : 1/1/12-12/31/12

Group Name Plan Year : 1/1/12-12/31/12. Find and Replace ( to be edited).

91 views • 0 slides